111 related articles for article (PubMed ID: 23902989)
1. Effects of chronic Akt/mTOR inhibition by rapamycin on mechanical overload-induced hypertrophy and myosin heavy chain transition in masseter muscle.
Umeki D; Ohnuki Y; Mototani Y; Shiozawa K; Fujita T; Nakamura Y; Saeki Y; Okumura S
J Pharmacol Sci; 2013; 122(4):278-88. PubMed ID: 23902989
[TBL] [Abstract][Full Text] [Related]
2. Protective Effects of Clenbuterol against Dexamethasone-Induced Masseter Muscle Atrophy and Myosin Heavy Chain Transition.
Umeki D; Ohnuki Y; Mototani Y; Shiozawa K; Suita K; Fujita T; Nakamura Y; Saeki Y; Okumura S
PLoS One; 2015; 10(6):e0128263. PubMed ID: 26053620
[TBL] [Abstract][Full Text] [Related]
3. Effects of bite-opening and cyclosporin A on the mRNA levels of myosin heavy chain and the muscle mass in rat masseter.
Arai C; Ohnuki Y; Umeki D; Saeki Y
Jpn J Physiol; 2005 Jun; 55(3):173-9. PubMed ID: 16080800
[TBL] [Abstract][Full Text] [Related]
4. Role of cyclic AMP sensor Epac1 in masseter muscle hypertrophy and myosin heavy chain transition induced by β2-adrenoceptor stimulation.
Ohnuki Y; Umeki D; Mototani Y; Jin H; Cai W; Shiozawa K; Suita K; Saeki Y; Fujita T; Ishikawa Y; Okumura S
J Physiol; 2014 Dec; 592(24):5461-75. PubMed ID: 25344550
[TBL] [Abstract][Full Text] [Related]
5. Effects of clenbuterol and cyclosporin A on the myosin heavy chain mRNA level and the muscle mass in rat masseter.
Arai C; Ohnuki Y; Umeki D; Hirashita A; Saeki Y
J Physiol Sci; 2006 Jun; 56(3):205-9. PubMed ID: 16839454
[TBL] [Abstract][Full Text] [Related]
6. Passive mechanical forces upregulate the fast myosin heavy chain IId/x via integrin and p38 MAP kinase activation in a primary muscle cell culture.
Hanke N; Kubis HP; Scheibe RJ; Berthold-Losleben M; Hüsing O; Meissner JD; Gros G
Am J Physiol Cell Physiol; 2010 Apr; 298(4):C910-20. PubMed ID: 20071689
[TBL] [Abstract][Full Text] [Related]
7. Role of masseter muscle β₂-adrenergic signaling in regulation of muscle activity, myosin heavy chain transition, and hypertrophy.
Ohnuki Y; Umeki D; Cai W; Kawai N; Mototani Y; Shiozawa K; Jin HL; Fujita T; Tanaka E; Saeki Y; Okumura S
J Pharmacol Sci; 2013 Sep; 123(1):36-46. PubMed ID: 23985574
[TBL] [Abstract][Full Text] [Related]
8. Enhanced expression of glucose transporter-1 in vascular smooth muscle cells via the Akt/tuberous sclerosis complex subunit 2 (TSC2)/mammalian target of rapamycin (mTOR)/ribosomal S6 protein kinase (S6K) pathway in experimental renal failure.
Lin CY; Hsu SC; Lee HS; Lin SH; Tsai CS; Huang SM; Shih CC; Hsu YJ
J Vasc Surg; 2013 Feb; 57(2):475-85. PubMed ID: 23265586
[TBL] [Abstract][Full Text] [Related]
9. Blockades of mitogen-activated protein kinase and calcineurin both change fibre-type markers in skeletal muscle culture.
Higginson J; Wackerhage H; Woods N; Schjerling P; Ratkevicius A; Grunnet N; Quistorff B
Pflugers Arch; 2002 Dec; 445(3):437-43. PubMed ID: 12466948
[TBL] [Abstract][Full Text] [Related]
10. Androgen replacement therapy improves function in male rat muscles independently of hypertrophy and activation of the Akt/mTOR pathway.
Hourdé C; Jagerschmidt C; Clément-Lacroix P; Vignaud A; Ammann P; Butler-Browne GS; Ferry A
Acta Physiol (Oxf); 2009 Apr; 195(4):471-82. PubMed ID: 18801052
[TBL] [Abstract][Full Text] [Related]
11. The mTOR/p70S6K signal transduction pathway plays a role in cardiac hypertrophy and influences expression of myosin heavy chain genes in vivo.
Boluyt MO; Li ZB; Loyd AM; Scalia AF; Cirrincione GM; Jackson RR
Cardiovasc Drugs Ther; 2004 Jul; 18(4):257-67. PubMed ID: 15367823
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor I-mediated skeletal muscle hypertrophy is characterized by increased mTOR-p70S6K signaling without increased Akt phosphorylation.
Song YH; Godard M; Li Y; Richmond SR; Rosenthal N; Delafontaine P
J Investig Med; 2005 Apr; 53(3):135-42. PubMed ID: 15921033
[TBL] [Abstract][Full Text] [Related]
13. Quantitative changes in the mRNA for contractile proteins and metabolic enzymes in masseter muscle of bite-opened rats.
Ohnuki Y; Saeki Y; Yamane A; Yanagisawa K
Arch Oral Biol; 2000 Dec; 45(12):1025-32. PubMed ID: 11084141
[TBL] [Abstract][Full Text] [Related]
14. Four-week rapamycin treatment improves muscular dystrophy in a fukutin-deficient mouse model of dystroglycanopathy.
Foltz SJ; Luan J; Call JA; Patel A; Peissig KB; Fortunato MJ; Beedle AM
Skelet Muscle; 2016; 6():20. PubMed ID: 27257474
[TBL] [Abstract][Full Text] [Related]
15. Activation of mammalian target of rapamycin induces lipid accumulation in the diaphragm of ventilated rats and hypoxia-treated C2C12 cells.
Yu T; Wang M; Wen Y; Cao Y; Shen G; Jiang X; Wu J; Lu W; Jin X
J Surg Res; 2018 May; 225():82-89. PubMed ID: 29605039
[TBL] [Abstract][Full Text] [Related]
16. Kinetic analysis of the slow skeletal myosin MHC-1 isoform from bovine masseter muscle.
Bloemink MJ; Adamek N; Reggiani C; Geeves MA
J Mol Biol; 2007 Nov; 373(5):1184-97. PubMed ID: 17900618
[TBL] [Abstract][Full Text] [Related]
17. Role of β-adrenergic signaling in masseter muscle.
Ito A; Ohnuki Y; Suita K; Ishikawa M; Mototani Y; Shiozawa K; Kawamura N; Yagisawa Y; Nariyama M; Umeki D; Nakamura Y; Okumura S
PLoS One; 2019; 14(4):e0215539. PubMed ID: 30986276
[TBL] [Abstract][Full Text] [Related]
18. Calcineurin and heat shock protein 72 in functionally overloaded rat plantaris muscle.
Oishi Y; Ogata T; Ohira Y; Taniguchi K; Roy RR
Biochem Biophys Res Commun; 2005 May; 330(3):706-13. PubMed ID: 15809055
[TBL] [Abstract][Full Text] [Related]
19. Calcineurin Co-regulates contractile and metabolic components of slow muscle phenotype.
Bigard X; Sanchez H; Zoll J; Mateo P; Rousseau V; Veksler V; Ventura-Clapier R
J Biol Chem; 2000 Jun; 275(26):19653-60. PubMed ID: 10777482
[TBL] [Abstract][Full Text] [Related]
20. Changes in PKB/Akt and calcineurin signaling during recovery in atrophied soleus muscle induced by unloading.
Sugiura T; Abe N; Nagano M; Goto K; Sakuma K; Naito H; Yoshioka T; Powers SK
Am J Physiol Regul Integr Comp Physiol; 2005 May; 288(5):R1273-8. PubMed ID: 15821284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
